Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Clinical Trial to Compare Adverse Birth Outcomes in Pregnant Women Receiving Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus Quadrivalent Inactivated Influenza Vaccine (IIV4)

NCT03969641 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03969641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03969641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Clinical Trial to Compare Adverse Birth Outcomes in Pregnant Women Receiving Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus Quadrivalent Inactivated Influenza Vaccine (IIV4)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
September 5, 2019
Completion date
September 29, 2021
Enrollment
384 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event following immunisation, birth outcomes, safety